1. Home
  2. LSAK vs MXCT Comparison

LSAK vs MXCT Comparison

Compare LSAK & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSAK
  • MXCT
  • Stock Information
  • Founded
  • LSAK 1997
  • MXCT 1999
  • Country
  • LSAK South Africa
  • MXCT United States
  • Employees
  • LSAK N/A
  • MXCT N/A
  • Industry
  • LSAK Investment Bankers/Brokers/Service
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • LSAK Finance
  • MXCT Health Care
  • Exchange
  • LSAK Nasdaq
  • MXCT Nasdaq
  • Market Cap
  • LSAK 408.0M
  • MXCT 361.8M
  • IPO Year
  • LSAK N/A
  • MXCT 2021
  • Fundamental
  • Price
  • LSAK $4.85
  • MXCT $2.76
  • Analyst Decision
  • LSAK
  • MXCT Strong Buy
  • Analyst Count
  • LSAK 0
  • MXCT 2
  • Target Price
  • LSAK N/A
  • MXCT $10.00
  • AVG Volume (30 Days)
  • LSAK 33.0K
  • MXCT 682.5K
  • Earning Date
  • LSAK 05-07-2025
  • MXCT 05-06-2025
  • Dividend Yield
  • LSAK N/A
  • MXCT N/A
  • EPS Growth
  • LSAK N/A
  • MXCT N/A
  • EPS
  • LSAK N/A
  • MXCT N/A
  • Revenue
  • LSAK $576,604,000.00
  • MXCT $38,627,000.00
  • Revenue This Year
  • LSAK $0.04
  • MXCT $9.05
  • Revenue Next Year
  • LSAK $1.74
  • MXCT $19.98
  • P/E Ratio
  • LSAK N/A
  • MXCT N/A
  • Revenue Growth
  • LSAK 5.39
  • MXCT N/A
  • 52 Week Low
  • LSAK $3.83
  • MXCT $2.62
  • 52 Week High
  • LSAK $5.60
  • MXCT $5.26
  • Technical
  • Relative Strength Index (RSI)
  • LSAK 50.19
  • MXCT 30.42
  • Support Level
  • LSAK $4.51
  • MXCT $2.62
  • Resistance Level
  • LSAK $5.10
  • MXCT $3.17
  • Average True Range (ATR)
  • LSAK 0.26
  • MXCT 0.17
  • MACD
  • LSAK 0.03
  • MXCT -0.01
  • Stochastic Oscillator
  • LSAK 66.67
  • MXCT 19.72

About LSAK Lesaka Technologies Inc.

Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

Share on Social Networks: